Essai clinique NCT05132075 · Non-Small Cell Lung Cancer
NCT05132075 — est «actif (non en recrutement)» sur ClinicalTrials.gov.
Essai clinique NCT05132075 (phase III) est «actif (non en recrutement)» sur ClinicalTrials.gov.
Pathologie: Non-Small Cell Lung Cancer · Interventions enregistrées: JDQ443, docetaxel · Dates enregistrées (source): 2022-06-15, 2026-09-03, 2021-11-24, 2026-09-25.
Résumé de l’étude (source : ClinicalTrials.gov, texte original en anglais):
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previously treated with a platinum-based chemotherapy and immune checkpoint inhibitor therapy either in sequence or in combination.